Impact of Denosumab in the Prevention of Bone Loss in Non-menopausal Women With Anorexia Nervosa (DIBLAN)
Sponsor: Nantes University Hospital
Terminated
Great difficulties were encountered during recruitment, for fear Denozumab. Only 2 patients have been included since the study start.
Other terminated trials from Nantes University Hospital
Other Anorexia Nervosa trials with similar outcome
Listed as NCT02567279, this PHASE3 trial focuses on Anorexia Nervosa and remains terminated or withdrawn. Sponsored by Nantes University Hospital, it has been updated 8 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Dec 2021 — Jul 2024 [monthly]
Terminated PHASE3
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE3
-
Nov 2020 — Jan 2021 [monthly]
Terminated PHASE3
▶ Show 3 earlier versions
-
Feb 2019 — Nov 2020 [monthly]
Terminated PHASE3
Status: Recruiting → Terminated
-
Jun 2018 — Feb 2019 [monthly]
Recruiting PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE3
First recorded
Jun 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Nantes University Hospital
- University Hospital, Lille
- University Hospital, Montpellier
- University Hospital, Paris
- University Hospital, Rouen
For direct contact, visit the study record on ClinicalTrials.gov .